cabergoline has been researched along with carboplatin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baylis, PH; Foster, S; Harris, PE; Hurel, SJ; Kelly, WF; McNicol, AM | 1 |
1 other study(ies) available for cabergoline and carboplatin
| Article | Year |
|---|---|
Metastatic prolactinoma: effect of octreotide, cabergoline, carboplatin and etoposide; immunocytochemical analysis of proto-oncogene expression.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cabergoline; Carboplatin; Ergolines; Etoposide; Female; Gene Expression; Humans; Immunohistochemistry; Indium Radioisotopes; Magnetic Resonance Imaging; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Mas; Proto-Oncogenes; Somatostatin; Treatment Failure | 1997 |